This Project will bring to market Minomic’s MiCheck® Prostate test, an algorithm driven, in-vitro diagnostic (IVD) test specifically designed to indicate the risk of aggressive prostate cancer and enable a consulting clinician to determine the need for a biopsy.The Project will fund validation tests in Australia, develop laboratory interfaces for MiCheck® Prostate’s web portal and cloud-based testing algorithm; develop logistics and reporting environment and market education; and fund market pricing studies and materials to engage clinicians in Australia, before an initial rollout to Australian Eastern seaboard urologists. See https://www.amgc.org.au/project/commercialisation-of-micheck-prostate/